Alzheimer's disease Trials in New Windsor, United States
Conditions / Alzheimer's disease / New Windsor, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05637801 | A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) | ACTIVE_NOT_RECRUITING | NA |
| NCT05575076 | Open-label Extension for Phase 3 Clinical Trials of Simufilam | TERMINATED | PHASE3 |
| NCT03823404 | GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease | COMPLETED | PHASE2/PHASE3 |
| NCT06585787 | A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) | RECRUITING | — |
| NCT02951598 | A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT06245031 | Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) | ENROLLING_BY_INVITATION | NA |
| NCT06721156 | A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) | RECRUITING | PHASE2 |
| NCT07011732 | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) | RECRUITING | — |
| NCT06937229 | A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) | RECRUITING | — |
| NCT05531526 | Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) | ACTIVE_NOT_RECRUITING | PHASE3 |